SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp Nasdaq-100 selloff has traders focused on heavyweight tech earnings and concerns that soaring AI spending may not deliver returns fast enough, with some attributing added pressure to month-end liquidation and margin calls. The community is split between fears of a deeper AI-led correction and dip buyers looking for a rebound.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weak fourth-quarter outlook, citing soft PC demand and manufacturing constraints, has driven a steep selloff, with analyst downgrades adding pressure. Traders are split between calling the drop an overreaction and buying the dip versus warning of further downside, while some see the move as part of a broader tech and semiconductor rout.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp, tech-led market selloff has put SPY in focus, with traders connecting the pressure to Amazon and Intel results and renewed concerns that heavy AI spending may not pay off. The discussion is largely bearish, with crash and liquidation fears competing against calls to buy the dip and expectations of a relief bounce.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

A broad tech and semiconductor selloff has weighed on Nvidia, as concerns about Big Techs heavy AI infrastructure spending and uncertain returns are compounded by fallout from Amazon and Intel results. Traders are divided between warning that the AI trade is a bubble and viewing the decline as an overreaction or buying opportunity, with some arguing AI demand remains intact.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is under pressure amid a broad semiconductor and tech selloff, with traders repeatedly pointing to Intels weak outlook and softer PC demand as a drag on chip sentiment, alongside concerns about AI valuations. Its 3x leverage magnifies the downturn; the community is split between dip buyers anticipating a rebound and bears warning of further losses and leverage decay.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is selling off sharply despite a strong quarterly beat, upbeat guidance and an announced 8-for-1 split, as traders debate whether the drop reflects a broader tech and AI-stock unwind or concerns that memory pricing and earnings growth are nearing a cyclical peak. Many call the decline an overreaction and are buying the dip, while bears point to slowing growth and possible peak-cycle risks.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares plunged after its quarterly report paired strong results with a weaker-than-expected outlook, declining Google search referrals and signs of slowing user growth; plans to push users toward a logged-in experience added concern about traffic and ad reach. Traders are split between calling the selloff an overreaction given Reddits growth and profitability, and warning that search dependence and potential user losses threaten future growth.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a broad technology and semiconductor selloff as investors question AI spending returns and elevated chip valuations, with Intels weak outlook adding to sector pressure. Traders disagree over whether AMDs decline is justified or sympathy selling ahead of its earnings report, citing its data-center opportunity as a counterpoint.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its earnings report is driving discussion, with traders pointing to analyst price-target cuts and concerns about ad-tech peers results and the broader market. Bulls argue the decline has made the companys valuation compelling, while bears fear weak results or guidance could bring further pressure.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins selloff is being linked mainly to a reported major Binance security breach, with traders also citing leveraged liquidations and weakness in tech stocks as added pressure. The community is split between fears of further selling and exchange-related security risks, and dip-buyers arguing the incident affected Binance rather than Bitcoin itself and that the price has held up relatively well.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug

Eton Pharmaceuticals licenses Aquestive's LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.read more...

TGTX Stock Rises 60% in 6 Months: Here's What You Should Know

TG Therapeutics shares climb 59.9% in six months on strong Briumvi sales uptake, higher 2026 revenue guidance and studies targeting additional indications.

Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases

MIRM's Livmarli meets the phase III EXPAND study goal, improving cholestatic pruritus and reducing serum bile acids, with an FDA filing planned for 2027.

ETON Stock Surges 108% in Six Months: Here's What You Need to Know

Eton's sales surge, raised 2026 outlook and expanding rare-disease portfolio are boosting confidence in its growth.

PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M

A substantial insider activity was disclosed on August 31, as V, Board Member at Eton Pharmaceuticals (NASDAQ:ETON), reported the exercise of a large sell of company stock options.
What Happened: A Form 4 filing withread more...

SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock

On August 20, a recent SEC filing unveiled that SEAN BRYNJELSEN, President & CEO at Eton Pharmaceuticals (NASDAQ:ETON) made an insider sell.
What Happened: According to a Form 4 filing with the U.S. Securities andread more...

Why Eton Pharmaceuticals Is Top of the Class Today

Key PointsEton Pharmaceuticals beat on both top and bottom lines last night...

This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day

Equity

Eton expects full-year 2026 revenue to exceed $145 million, up from its previous forecast of more than $120 million.

Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday

U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.read more...

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.read more...

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Neutral Sentiment

<ul class="summary-bullets"><li>Eton’s Q2 revenue and earnings beat was driven by sales of its oral medication used to treat benign blood-vessel growths.</li><li>The company raised its adjusted earnings before interest, taxes, depreciation and amortization margin outlook to at least 35%, from at least 30%.</li><li>B. Riley lifted the target to $70 from $40 and kept a ‘Buy’ rating, according to The Fly.</li></ul>Eton Pharmaceuticals (ETON) shares surged 40% to an all-time high on Friday, after better-than-expected second-quarter results sparked bullish action across Wall Street.<a href="https://stocktwits.com/symbol/ETON">ETON shares</a> are also on track to record their biggest-ever single-day gains.<h2 class="st-heading-2">Hemangeol Relaunch Powers Q2 Revenue Beat</h2>Eton reported second-quarter revenue of $37.6 million, up 99% from a year earlier and comfortably beating Wall Street’s estimates of $27.1 million, according to Fiscal.ai data. Diluted earnings of $0.35 per share also comfortably surpassed analysts’ expectations of $0.1 per share.The strong performance was driven largely by Hemangeol, which Eton relaunched in May. Hemangeol is an oral medication used to treat proliferating infantile hemangiomas – benign blood-vessel growths that typically appear in babies. Eton also said the conversion of Hemangeol patients to its commercial platform was completed ahead of schedule.H.C. Wainwright raised the price target to $70 from $65 and maintained a ‘Buy’ rating, according to The Fly. This represents a 23% upside from current levels. The firm said the “speedy” conversion implies Eton’s current guidance is conservative.Eton expects full-year 2026 revenue to exceed $145 million, up from its previous forecast of more than $120 million. It also raised its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin outlook to at least 35%, from at least 30%.<h2 class="st-heading-2">Wall Street Raises Price Targets</h2>Meanwhile, B. Riley lifted the target sharply to $70 from $40 and kept a ‘Buy’ rating, calling the quarter Eton’s “strongest-ever beat and raise.” Canaccord also increased its target to $68 from $60 while retaining a ‘Buy’ rating.The stock has a consensus 12-month price target of $62.33, according to Koyfin data, while all four analysts covering the stock have a ‘Buy’ rating.<h2 class="st-heading-2">What Is Retail’s Take On ETON?</h2>Retail sentiment surrounding ETON on Stocktwits flipped to ‘extremely bullish’ from ‘neutral’ over the past 24 hours, amid a 2,800% surge in message volumes.One user believes it’s a great company with fair value.<stembedurl>https://stocktwits.com/AMP19/message/661906270</stembedurl>The stock has rallied more than 235% so far in 2026.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-valn-stock-surge-24-today/cZotV7rRJ0j">Why Did VALN Stock Surge 24% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of US pharma company eton PHARMACEUTICALS Inc is displayed on a smartphone in front of abstract background on computer screen. (Photo Illustration by Timon Schneider/SOPA Images/LightRocket via Getty Images)

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$52.07
Prev Close	$53.67
Open	$53.04
Dividend Yield	0.00%
50-Day Moving Average	$56.16
Beta	0.79
Avg. Volume	542,066.72
PE Ratio	141.91

52-Week High	$66.37
52-Week Low	$14.27
Market Capitalization	$1.53B
EPS (Annual)	-$0.171
Price to Book	32.59
Revenue Per Employee	$1.82M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ETON Fundamentals